# MoonLake Immunotherapeutics: Form SCHEDULE 13D/A, filed Nov 10, 2025

- Company: [MoonLake Immunotherapeutics](/companies/mltx.md) (CIK 1821586)
- Form: SCHEDULE 13D/A
- Filed: 2025-11-10
- Accepted by EDGAR: Nov 10, 2025, 17:27 ET
- Period: not reported
- Accession: 0000921895-25-002943
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1821586/000092189525002943/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1821586/000092189525002943/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1821586/000092189525002943/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Nov 10, 2025.
Source: SEC EDGAR, the filing index for accession 0000921895-25-002943. Last ingested by Listed: Nov 4, 2026, 07:34 ET. No prices; not investment advice.